>TEVA--Dew, did you sell because you had reached a predetermined sell point or because you thought that TEVA has risen quickly and might not be able to maintain the pace in the short term?<
Those sound like two ways of saying the same thing: that the valuation is not so compelling after the 50% rise off the early-2005 lows. I don’t impose a hard and fast sell price for a stock, but rather reevaluate each holding on a continuous basis.
I still like TEVA a lot on a longer-term basis because:
1. Generic drugs are the best answer to rising healthcare costs, as you point out;
2. TEVA’s execution is second to none; and
3. TEVA and NVS are probably the only two companies with the resources to exploit generic biologics, when the day finally dawns for these products.
--
By the way, I feel the same way about NVS as I do about TEVA: a great company that I sold for valuation reasons only.
If TEVA continues to rise above 40 before I get eventually back in, so be it. Every decision has a risk. Regards, Dew
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
